Clinical Trials Directory

Trials / Terminated

TerminatedNCT04278664

Telemedicine in Pregnant Women With Type 1 Diabetes Mellitus

Effect of Telemedicine on Outcomes in Pregnant Women With Type 1 Diabetes Mellitus

Status
Terminated
Phase
Study type
Observational
Enrollment
5 (actual)
Sponsor
Ana Braescu · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hypothesize that co-managing pregnant type 1 diabetics with telemedicine will have at least equivalent outcomes to those managed with standard care. Comparison of outcomes between pregnant type 1 diabetics being co-managed with telemedicine compared to those receiving conventional care will help identify unanswered clinical questions and areas for improvement in regard to standards of care for pregnant type 1 diabetics. The data generated from this analysis will help determine whether telemedicine can be an effective additional means of care for pregnant type 1 diabetic patients.

Detailed description

Few studies have researched the use of telemedicine in the management of type 1 diabetes during pregnancy. These studies are additionally limited due to the number of patients as well as several secondary outcomes reported. Therefore, this study will enroll 100 participants to reach a power of 81.8% with HbA1c as a primary outcome and secondary outcomes related to diabetic management such as frequency of hypoglycemia, antenatal hospital stay (percentage requiring admission, length of stay), miscarriage, cesarean section rates, induction of labor, fetal birth weight, gestational age at birth or preterm birth (\<34 weeks, \<37 weeks), frequency of neonatal hypoglycemia, shoulder dystocia, neonatal death, major and minor anomalies, and neonatal intensive care admission.

Conditions

Timeline

Start date
2015-07-01
Primary completion
2017-11-01
Completion
2017-11-01
First posted
2020-02-20
Last updated
2022-08-30

Source: ClinicalTrials.gov record NCT04278664. Inclusion in this directory is not an endorsement.